1. Home
  2. PTON vs ADPT Comparison

PTON vs ADPT Comparison

Compare PTON & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Peloton Interactive Inc.

PTON

Peloton Interactive Inc.

HOLD

Current Price

$6.33

Market Cap

2.6B

ML Signal

HOLD

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

HOLD

Current Price

$17.56

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTON
ADPT
Founded
2012
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.5B
IPO Year
2019
2019

Fundamental Metrics

Financial Performance
Metric
PTON
ADPT
Price
$6.33
$17.56
Analyst Decision
Buy
Strong Buy
Analyst Count
13
10
Target Price
$9.68
$16.60
AVG Volume (30 Days)
8.2M
2.1M
Earning Date
02-05-2026
02-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,455,600,000.00
$252,754,000.00
Revenue This Year
$1.53
$50.86
Revenue Next Year
$1.42
$0.53
P/E Ratio
N/A
N/A
Revenue Growth
N/A
42.57
52 Week Low
$4.63
$6.26
52 Week High
$10.25
$20.76

Technical Indicators

Market Signals
Indicator
PTON
ADPT
Relative Strength Index (RSI) 45.77 55.74
Support Level $6.40 $15.45
Resistance Level $7.02 $18.39
Average True Range (ATR) 0.35 0.84
MACD 0.04 0.15
Stochastic Oscillator 36.27 68.50

Price Performance

Historical Comparison
PTON
ADPT

About PTON Peloton Interactive Inc.

Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product derives revenue from the portfolio of Connected Fitness Products and related accessories, as well as Precor-branded fitness products, delivery and installation services, Peloton Bike portfolio rental products, extended warranty agreements, branded apparel, and commercial service contracts. Subscription revenue is derived from monthly Subscription fees. The company generates maximum revenue from the Subscription segment. Geographically, the company derives a majority of its revenue from North America and the rest from International markets.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Share on Social Networks: